Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. GRCE
GRCE logo

GRCE News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

GRCE News

Pomerantz LLP Investigates Grace Therapeutics for Securities Fraud

6d agoPRnewswire

Grace's Drug FDA Rejection Leads to Stock Plunge

Apr 24 2026stocktwits

Grace Therapeutics Faces FDA Rejection for New Drug Application

Apr 24 2026NASDAQ.COM

FDA Rejects Grace Therapeutics Drug Application

Apr 23 2026stocktwits

FDA Issues Complete Response Letter for GTx-104 Application

Apr 23 2026Newsfilter

GRACE THERAPEUTICS, INC - FDA WAIVES REQUEST FOR FURTHER CLINICAL DATA ON GTX-104 NDA

Apr 23 2026moomoo

Grace Therapeutics' GTx-104 NDA Accepted by FDA, Key Decision Approaches

Apr 22 2026stocktwits

Grace Therapeutics Q3 Earnings Beat Expectations

Feb 12 2026seekingalpha

GRCE Events

05/12 08:50
Significant Increases in Indicative Borrow Rates for Liquid Options
Latest data shows the largest indicative borrow rate increases among liquid option names include: Pluralsight Inc (PS) 290.72% +39.91, Grace Therapeutics, Inc (GRCE) 6.95% +4.26, Serve Robotics Inc (SERV) 22.60% +4.25, SoundHound AI (SOUN) 34.54% +3.04, T-REX 2X LONG MSTR DAILY TARGET (MSTU) 19.75% +2.07, T-REX 2X Long BMNR Daily Target ETF (BMNU) 16.49% +1.98, BigBearai Holdings (BBAI) 3.80% +1.89, Kodiak AI, Inc. Common Stock (KDK) 86.11% +1.08, Bilibili (BILI) 3.61% +1.01, and Tradr 2X Long QBTS Daily ETF (QBTX) 30.40% +1.00.
05/11 08:50
Significant Borrow Rate Increases Among Liquid Option Names
Latest data shows the largest indicative borrow rate increases among liquid option names include: Xanadu Quantum Technologies Limited Class B (XNDU) 108.67% +13.18, YIELDMAX MSTR OPTION INCOME STRATEGY ETF (MSTY) 11.79% +2.98, Grace Therapeutics, Inc (GRCE) 4.90% +1.63, Tradr 2X Long QBTS Daily ETF (QBTX) 18.40% +1.61, Direxion S&P Biotech Bear 3X (LABD) 15.74% +1.36, Kodiak AI, Inc. Common Stock (KDK) 31.81% +1.21, Anheuser Busch (BUD) 2.34% +1.07, GraniteShares 2x Long IONQ Daily ETF (IONL) 27.15% +0.91, Grupo Financiero (GGAL) 1.36% +0.59, and inTest (INTT) 3.91% +0.50.

GRCE Monitor News

FDA Issues Complete Response Letter for Grace Therapeutics' GTx-104

Apr 23 2026

GRCE Earnings Analysis

No Data

No Data

People Also Watch